Select Bibliography

Filter by any of these (after searching):

N047D

AUTHOR ABSTRACT DEADLINES

A meeting abstract must be submitted by the first or corresponding author to the Alliance Publications Coordinator (publications@AllianceNCTN.org) at least two weeks prior to the meeting abstract submission deadline. For detailed information about Alliance Publications guidelines, please refer to the policies, along with the author abstract deadlines.

There are 2 items

The relationship between six-month progression-free survival and 12-month overall survival end points for phase II trials in patients with glioblastoma multiforme

Ballman, Karla V. , Buckner, Jan C. , Brown, Paul D. ... - - Neuro-oncol - 2007

Manuscript - Primary - Primary - Neuro-Onc - N047D

Correlation of response with survival endpoints in patients with newly diagnosed and recurrent glioblastoma (GBM) treated on prospective North Central Cancer Treatment Group (NCCTG) clinical trials

Jaeckle, K. A. , Wu, W. , Kosel, M. , Flynn, P. J. ... - ASCO - J. Clin. Oncol. - 2008

Abstract - Primary - Primary - Neuro-Onc - N047D